000 | 01940 a2200517 4500 | ||
---|---|---|---|
005 | 20250513110823.0 | ||
264 | 0 | _c19970115 | |
008 | 199701s 0 0 eng d | ||
022 | _a0884-0431 | ||
024 | 7 |
_a10.1002/jbmr.5650110415 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEndo, N | |
245 | 0 | 0 |
_aHuman protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates. _h[electronic resource] |
260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cApr 1996 |
||
300 |
_a535-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAlternative Splicing |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 |
_aBone Neoplasms _xpathology |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aChromosomes, Human, Pair 6 _xmetabolism |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 |
_aCytoplasm _xmetabolism |
650 | 0 | 4 |
_aDNA, Complementary _xchemistry |
650 | 0 | 4 |
_aDiphosphonates _xtoxicity |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aOsteosarcoma _xpathology |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xdrug effects |
650 | 0 | 4 |
_aRNA _xgenetics |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aVanadates _xtoxicity |
700 | 1 | _aRutledge, S J | |
700 | 1 | _aOpas, E E | |
700 | 1 | _aVogel, R | |
700 | 1 | _aRodan, G A | |
700 | 1 | _aSchmidt, A | |
773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 11 _gno. 4 _gp. 535-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.5650110415 _zAvailable from publisher's website |
999 |
_c8984265 _d8984265 |